PA-PROJECT-MANAGEMENT-IN
13.7.2020 15:02:09 CEST | Business Wire | Press release
Project Management Institute (PMI) today announced its first annual Future 50 list, which features the 50 next generation leaders that are creating, building, and transforming the world through notable projects. The 50 young standout project leaders highlighted in the specially dedicated July/August issue of PM Network ® magazine represent the wave of change and talent around the globe—a youthquake that will reshape the future and accelerate innovation in the here and now. Honorees include groundbreaking achievements from people across a variety of industries and countries, including Director Greta Gerwig, Laura Jones from the Special Olympics and Miishe Addy from Jetstream Africa.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200713005075/en/
“As a new generation of leaders rise around the world we are seeing them have additional guiding principles and motivations when compared to earlier generations. Organizations are already rethinking how they can attract, retain and help foster this generation of talent,” said Sunil Prashara, President and CEO of Project Management Institute. “This next generation of project leaders are deeply committed to driving change across the world – from having a deep sense of social responsibility and improving the environment to driving diversity and inclusion. The 50 individuals featured on this list are some of the biggest change makers of their generation. They exemplify the power and transformative change that can happen through projects.”
As part of the July/August issue of PM Network , PMI interviewed this year’s Future 50 winners and other seasoned professionals around the globe to uncover ways to encourage this next generation of talent. The issue also outlines six rules to harness the power of these future-focused professionals, including igniting a learning culture; picking up the pace of development; a flatter, more communicative leadership team; more purpose-driven work; and constant, iterative feedback.
To identify this year’s Future 50 honorees, PMI reached out to hundreds of experts and stakeholders across the globe for nominations. A special committee vetted the rising project professionals and narrowed the options. Finalists were then individually researched and/or interviewed to create a list that represents the full spectrum of regions, industries and achievements in The Project Economy – where work increasingly centers around executing projects both large and small. While some honorees are Project Management Professional (PMP)® credential holders, others would not even describe themselves as project managers. What unites the Future 50 is a commitment to project work as the foundation of positive impact, for today and tomorrow.
To learn more about the complete list of honorees and the rules to drive this next generation of talent, visit PMI.org/Future50 .
The 50 Future Leaders to Watch:*
- Abdullah Seflan, Saudi Aramco
- Ada Osakwe, Qantas
- Adam Fahrenkopf, Google
- Alagesan Hanippuya, RHB Banking Group
- Andrew Walters, National Australia Bank
- Arman Köklü, GE
- Bilel Manai, Al Bawsala
- Boyan Slat, The Ocean Cleanup
- Rep. Bryan Steil, United States House of Representatives
- Charlyn Johnson, UK Ministry of Justice
- Diletta Invernizzi, Jacobs
- Gabriel Costa Caldas, Alpha Ports
- Geetha Gopal, Panasonic
- Gillian Dowds, BAE Systems Maritime
- Gregory Daniels, Zoom
- Greta Gerwig, Director
- Greta Thunberg, Climate Change Activist
- Hayden Brown, Upwork
- Janeen Blige, IBM
- Jaspreet Dol, DXC
- Jenk Oz, Thred
- Jia Song, Didi
- Jonathan Kadishson, Burns & McDonnell
- Julissa Mateo Abad, Bunker
- Kamil Mroz, UCB
- Kaspar Korjus, PactumAI
- Katerina Treppeschova, Facebook
- Kenneth Harris II, NASA
- Laura Jones, Special Olympics
- Leanne Pittsford, Include.io/Lesbians Who Tech
- Lijuan Gao, NICE
- Marina Tranchitella, Sport Club Internacional
- Miishe Addy, Jetstream Africa
- Pascale Sablan, S9 Architecure
- Rajesh Kumar Nalla, Techimax IT
- Prime Minster Sanna Marin, Government of Finland
- Sevi Rich, BHP
- Sitanshu Dash, Adobe
- Stephen Xu, Alibaba
- Taiwo Abraham, Horizant
- Tamara Kotevska, Documentary Producer
- Tiago Chavez Oliveira, Government of Brazil
- Tim Kaltwasser, Airbus
- Vidhya Abhjith, Codewave Tech
- Vihari Kanukollu, UrbanKisaan
- Wanja Murekio, Safaricom
- Whitney Wolfe Herd, Bumble
- Ye Fei, ZTE
- Yingjin Liu, DSM
- Yoftahe Yohannes, Ericsson
*All product names, logos, and brands are the property of their respective owners
About Project Management Institute (PMI)
Project Management Institute (PMI) is the world's leading association for those who consider project, program or portfolio management their profession. Through global advocacy, collaboration, education and research, we work to prepare more than three million professionals around the world for The Project Economy: the coming economy in which work, and individuals, are organized around projects, products, programs and value streams. Now 50 years in the making, we work in nearly every country around the world to advance careers, improve organizational success and further mature the project management profession through globally-recognized standards, certifications, communities, resources, tools, academic research, publications, professional development courses and networking opportunities. As part of the PMI family, ProjectManagement.com creates online global communities that deliver more resources, better tools, larger networks and broader perspectives. Visit us at www.PMI.org , www.projectmanagement.com www.facebook.com/PMInstitute and on Twitter @PMInstitute.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200713005075/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom